Palisade Bio, Inc.

NasdaqCM:PALI 주식 보고서

시가총액: US$3.3m

Palisade Bio 대차 대조표 상태

재무 상태 기준 확인 6/6

Palisade Bio has a total shareholder equity of $9.9M and total debt of $349.0K, which brings its debt-to-equity ratio to 3.5%. Its total assets and total liabilities are $12.9M and $2.9M respectively.

주요 정보

3.5%

부채 비율

US$349.00k

부채

이자 보상 비율n/a
현금US$11.35m
주식US$9.95m
총 부채US$2.92m
총 자산US$12.87m

최근 재무 상태 업데이트

Palisade Bio (NASDAQ:PALI) Will Have To Spend Its Cash Wisely

Mar 28
Palisade Bio (NASDAQ:PALI) Will Have To Spend Its Cash Wisely

Recent updates

Palisade Bio announces CEO transition

Oct 11

Palisade Bio streamlines operations, including cutting 20% of employees

Sep 15

Palisade Bio GAAP EPS of -$0.12

Aug 15

Palisade Bio begins phase 3 study testing LB1148 for postoperative return of bowel function

Jul 27

Palisade Bio rises 10% after starting phase 3 study of gastrointestinal surgery therapy

Jun 29

Palisade Bio (NASDAQ:PALI) Will Have To Spend Its Cash Wisely

Mar 28
Palisade Bio (NASDAQ:PALI) Will Have To Spend Its Cash Wisely

Palisade Bio: Guarding Intestinal Integrity

Nov 07

재무 상태 분석

단기부채: PALI's short term assets ($12.3M) exceed its short term liabilities ($2.8M).

장기 부채: PALI's short term assets ($12.3M) exceed its long term liabilities ($86.0K).


부채 대 자본 내역 및 분석

부채 수준: PALI has more cash than its total debt.

부채 감소: PALI had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


대차 대조표


현금 런웨이 분석

과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.

안정적인 현금 활주로: PALI has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.

예측 현금 활주로: PALI is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.


건강한 기업 발견하기